Bayer has announced an agreement to acquire the cell therapy company BlueRock Therapeutics, and plans to open a clinical trial of a potential Parkinson’s stem cell-based treatment this year.
With BlueRock Acquisition, Bayer Plans to... - Cure Parkinson's
With BlueRock Acquisition, Bayer Plans to Open Trial of Cell Therapy for Parkinson’s
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Ha, that's an oxymoron for sure...
Not what you're looking for?
You may also like...
Bayer reports positive early data for Parkinson’s cell therapy
12-person clinical trial....
1st transplant done in trial of Parkinson’s cell therapy ANPD001
experimental therapy for Parkinson’s uses a type of stem cell called an induced pluripotent stem...
Parkinson’s disease stem cell therapy research update
for stem cells for Parkinson’s....
Bayer Subsidiary Gets Fast-track Status for Parkinson's Treatment in U.S.
major Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday that its clinical stage cell therapy...
Stem cell treatment Parkinson’s
Legit Stem Cell therapy for Parkinson’s, particularly young onset
I’d like to know if anyone knows...